Using the evolution of psoriasis therapies over the past several decades as a backdrop, Steven Feldman, MD, PhD, discusses the conundrums, accomplishments, and promises in the treatment of psoriasis, from the problem of patient noncompliance in the treatment of the disease's milder expressions, to the successes of current regimens for more severe forms, and finally, to the looming benefits of biosimilars.
Medscape © 2022 WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Complexities, Achievements, and Unmet Needs in the Treatment of Psoriasis - Medscape - Feb 15, 2022.
Comments